Berman Mark A. 4
4 · Better Therapeutics, Inc. · Filed Apr 21, 2023
Insider Transaction Report
Form 4
Berman Mark A.
Chief Medical Officer
Transactions
- Award
Common Stock
2023-04-05+101,450→ 333,389 total - Award
Stock Option (Right to Buy)
2023-03-01+101,450→ 101,450 totalExercise: $1.14Exp: 2033-02-28→ Common Stock (101,450 underlying)
Footnotes (2)
- [F1]The shares represent restricted stock units (each, an "RSU") granted on April 5, 2023, which vest as to 1/2 of the shares on March 24, 2024 and the remaining shares vest on March 24, 2025, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The stock option vests as to 1/4 of the shares subject to the stock option on March 1, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on March 1, 2023.